New Delhi: Vishwasrao Salunkhe is a well-known leader in the healthcare information technology arena who has been in practice for over 15 years and has extensive experience in EHR data (Electronic ...

In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...

Now at 32, he continues to live with the condition while endorsing advancements in diabetes care, particularly the Dexcom G7 glucose monitoring system, which he says has empowered him to manage ...

Shares traded 8.5% higher at $72.55. The company, which focuses on glucose biosensing--which measures glucose levels in wearers--said that the Food and Drug Administration has cleared the Dexcom G7 15 ...

In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system. Shares of the ...

Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, outperforms traditional markers in ...